KRYS · earnings call history
Krystal Biotech Q2 FY26 — Strong VYJUVEK Performance and Advancing Pipeline
Read the briefKrystal Biotech Q1 FY26 — Strong VYJUVEK Growth and Pipeline Advancement
Read the briefBrowse all US companies on the earnings-call register.